Figure 1 Tropical sprue and PI-IBS

Slides:

Advertisements

Similar presentations

Malabsorption 9/14/ CONDITIONS OF MALABSORPTION Malabsorption: is the inability of the digestive system to absorb one or more of The major vitamins(

Advertisements

Schilling TestUrinary D-Xylose Test Radiologic Examination Use -determine the cause for cobalamin malabsorption -assess the integrity of stomach, pancreas,

Disorders of Malabsorption. Malabsorption It is a descriptive term of many diseases and is not a diagnosis It is a descriptive term of many diseases and.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Low-grade inflammation in FGID

Figure 2 Endoscopic imaging of intestinal villi

Figure 2 Enteroids can model transport physiology

Figure 4 The gut microbiota directly influences T-cell differentiation

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Imaging of a depressed intramucosal carcinoma

Figure 4 Activation of clopidogrel via cytochrome P450

Figure 5 Therapeutic paradigms for interfering with the brain–gut axis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

IRRITABLE BOWEL SYNDROME

Figure 2 A stage-based approach to the treatment of NAFLD

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 The T-cell cytokine tree in IBD

Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Outline of the pathogenesis and overlap

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 The concept of the hepatic reserve and ACLF

Figure 3 The 'leaky gut' hypothesis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Suggested biopsy-avoiding diagnostic pathway for coeliac disease Figure 1 | Suggested biopsy-avoiding diagnostic pathway for coeliac disease.

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Figure 1 Definition and concept of ACLF

Figure 1 Host range of hepatitis E virus

Figure 2 Switching of biologic agents and biosimilars

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Example wireless motility recording

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 7 Example colonic high-resolution manometry

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 13C-octanoic acid gastric emptying breath test

Figure 1 Median coverage and distribution by

Figure 4 Functional luminal imaging probe

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 5 High-resolution manometry studies performed

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Assessment of colonic transit time with radiopaque markers

Figure 2 New therapeutic approaches in IBD with their specific targets

Figure 5 Systems biological model of IBS

Individual patients’ FCP (μg/g) values (n=119).

Figure 5 PPIs and adverse events with proven and unproven causality

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Lifelong influences on the gut microbiome from

Figure 1. Changes of Clinical Symptoms Severity in patients on multi-strain probioticFlorasan-D or Placebo Ivashkin V. et al. The Effect of a Multi-strain.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 8 Assessment of colonic tone using a barostat device

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Endomicroscopy for optical intestinal biopsy

Presentation transcript:

Figure 1 Tropical sprue and PI-IBS Figure 1 | Tropical sprue and PI-IBS. a | Outcomes of acute infectious gastroenteritis. Although 80–90% of patients recover completely, 10–20% continue to have bowel dysfunction either due to post-infectious irritable bowel syndrome (PI-IBS) or post-infectious malabsorption syndrome, also known as tropical sprue (TS). Tests for mucosal malabsorption (D-xylose, faecal fat level estimation, vitamin B12 absorption and endoscopic duodenal biopsy) are needed to differentiate between these two conditions. Whereas in PI-IBS these tests would be normal, at least two of these tests would be abnormal in patients with tropical sprue. b | Number of publications per year on PI-IBS and tropical sprue from 1928 to 2016. PubMed searches were performed using the terms “tropical sprue” and “PI IBS”. Although the number of publications on tropical sprue has declined in the past decades, there has been a corresponding increase in publications on PI-IBS. Ghoshal, U. C. & Gwee, K.-A. (2017) Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.37